Potential impact of existing interventions and of antiretroviral use in female sex workers on transmission of HIV in Burkina Faso: A modeling study

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue , 2015, Pages S180-S188

  Low, Andrea ^a   Nagot, Nicolas ^b   Konate, Issouf ^c   Meda, Nicolas ^c   Segondy, Michel ^b   Van De Perre, Philippe ^b   Mayaud, Philippe ^a   Vickerman, Peter ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIV MONTPELLIER   (France)

^c CENTRE MURAZ   (Burkina Faso)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antiretrovirals; Burkina Faso; Female sex worker; HIV transmission; Modeling; Treatment as prevention

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; BURKINA FASO; CD4 LYMPHOCYTE COUNT; COMPARTMENT MODEL; CONDOM USE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH SURVEY; HETEROSEXUALITY; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; PRIORITY JOURNAL; PROSTITUTION; SEXUAL PRACTICE; SEXUAL TRANSMISSION; VIRUS TRANSMISSION; BIOLOGICAL MODEL; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; EPIDEMIC; HIV INFECTIONS; MALE; RISK FACTOR; TRANSMISSION; UNSAFE SEX;

ANTI-HIV AGENTS; BURKINA FASO; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; EPIDEMICS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MODELS, BIOLOGICAL; RISK FACTORS; SEX WORKERS; UNSAFE SEX;

EID: 84924513890     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000441     Document Type: Article

References (79)

1. Wilson DP. HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLoS Med. 2012;9:e1001231.
2. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092-2098.
3. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
4. Anglemyer A, Rutherford G, Horvath HT, et al. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev. 2013;4:1-53.
5. Baggaley RF, White RG, Hollingsworth TD, et al. Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples. Epidemiology. 2013;24:110-121.
6. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and metaanalysis. AIDS. 2009;23:1397-1404.
7. Jia Z, Ruan Y, Li Q, et al. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study. Lancet. 2012;382:1195-1203.
8. Tanser F, Barnighausen T, Grapsa E, et al. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966-971.
9. Birungi J, Wang H, Ngolobe M, et al. Lack of effectiveness of antiretroviral therapy (ART) as an HIV prevention tool for serodiscordant couples in a rural ART program without viral load monitoring in Uganda. In: Society IA, ed. 19th International AIDS Conference. Washington, DC; July 22-27, 2012.
10. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5:e11068.
11. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.
12. UNAIDS 2010. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Available at: http://www.who.int/hiv/pub/2010progressreport/en/. Accessed May 3, 2012.
13. Wagner BG, Blower S. Universal access to HIV treatment versus universal "test and treat": transmission, drug resistance & treatment costs. PLoS One. 2012;7:e41212.
14. Cohen MS, Smith MK, Muessig KE, et al. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet. 2013;382:1515-1524.
15. Eaton J, Menzies N, Stover J, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014;2:e23-e34.
16. Walensky RP, Ross EL, Kumarasamy N, et al. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2013;369:1715-1725.
17. Vickerman P, Terris-Prestholt F, Delany S, et al. Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa. Sex Transm Dis. 2006;33(10 suppl):S122-S132.
18. Vickerman P, Watts C, Delany S, et al. The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings. Sex Transm Dis. 2006;33:397-405.
19. Baral S, Beyrer C, Muessig K, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:538-549.
20. Lowndes CM, Alary M, Meda H, et al. Role of core and bridging groups in the transmission dynamics of HIV and STIs in Cotonou, Benin, West Africa. Sex Transm Infect. 2002;78(suppl 1):i69-i77.
21. Cote AM, Sobela F, Dzokoto A, et al. Transactional sex is the driving force in the dynamics of HIV in Accra, Ghana. AIDS. 2004;18:917-925.
22. Gomes do Espirito Santo ME, Etheredge GD. Male clients of brothel prostitutes as a bridge for HIV infection between high risk and low risk groups of women in Senegal. Sex Transm Infect. 2005;81:342-344.
23. Cohen MS, Muessig KE, Smith MK, et al. Antiviral agents and HIV prevention: controversies, confl icts, and consensus. AIDS. 2012;26:1585-1598.
24. Mishra S, Mountain E, Pickles M, et al. Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention context. AIDS. 2014;28(suppl 1):S61-S72.
25. Kato M, Granich R, Duong D, et al. The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission. J Acquir Immune Defic Syndr. 2013;63:e142-e149.
26. Delva W, Eaton JW, Meng F, et al. HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med. 2012;9:e1001258.
27. Williams JR, Alary M, Lowndes CM, et al. Positive impact of increases in condom use among female sex workers and clients in a medium HIV prevalence epidemic: modelling results from project SIDA1/2/3 in Cotonou, Benin. PLoS One. 2014;9:e102643.
28. Nagot N, Meda N, Ouangre A, et al. Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV control. Sex Transm Infect. 2004;80:124-129.
29. Meda N, Cartoux M, Dabis F, et al. Stabilization of HIV infection rates in urban Burkina Faso, 1995-1999. Int J STD AIDS. 2001;12:460-462.
30. Nagot N, Ouangre A, Ouedraogo A, et al. Spectrum of commercial sex activity in Burkina Faso: classification model and risk of exposure to HIV. J Acquir Immune Defic Syndr. 2002;29:517-521.
31. Nagot N, Ouedraogo A, Ouangre A, et al. Is sexually transmitted infection management among sex workers still able to mitigate the spread of HIV infection in West Africa? J Acquir Immune Defic Syndr. 2005;39:454-458.
32. Berthe A, Huygens P, Ouattara C, et al. Understanding and reaching young clandestine sex workers in Burkina Faso to improve response to HIV [in French]. Sante. 2008;18:163-173.
33. Berthe A, Huygens P. Communicating with vulnerable women for positive behaviour change: the Yerelon project in Bobo Dioulasso (Burkina Faso) [in French]. Sante. 2007;17:103-109.
34. Vandepitte J, Lyerla R, Dallabetta G, et al. Estimates of the number of female sex workers in different regions of the world. Sex Transm Infect. 2006;82(suppl 3):iii18-iii25.
35. Institut National de la Statistique et de la Demographie Ministere de l'Economie et des Finances 1998. Burkina Faso DHS, 1998-1999. Available at: http://www.measuredhs.com/publications/publication-FR110-DHS-Final-Reports.cfm. Accessed December 10, 2012.
36. Lagarde E, Congo Z, Meda N, et al. Epidemiology of HIV infection in urban Burkina Faso. Int J STD AIDS. 2004;15:395-402.
37. ICF International 2003. Demographic and health Surveys: EDSBF-III Burkina Faso. Available at http://dhsprogram.com/publications/publication-FR154-DHS-Final-Reports.cfm. Accessed September 15, 2012.
38. Bureau d'Appui en Sante Publique 2011. Enquete de surveillance comportementale aupres des groupes a haut risque: travailleuses de sexe (TS) et leurs clients au Burkina Faso: Rapport Final. Burkina Faso. 2011.
39. Konate I, Traore L, Ouedraogo A, et al. Linking HIV prevention and care for community interventions among high-risk women in Burkina Faso-the ARNS 1222 "Yerelon" cohort. J Acquir Immune Defic Syndr. 2011;57(suppl 1):S50-S54.
40. Lankoande S, Meda N, Sangare L, et al. Prevalence and risk of HIV infection among female sex workers in Burkina Faso. Int J STD AIDS. 1998;9:146-150.
41. Lankoande S, Meda N, Sangare L, et al. HIV infection in truck drivers in Burkina Faso: a seroprevalence survey [in French]. Med Trop (Mars). 1998;58:41-46.
42. Buve A, Lagarde E, Carael M, et al. Interpreting sexual behaviour data: validity issues in the multicentre study on factors determining the differential spread of HIV in four African cities. AIDS. 2001;15(suppl 4): S117-S126.
43. Meda N, Ledru S, Fofana M, et al. Sexually transmitted diseases and human immunodeficiency virus infection among women with genital infections in Burkina Faso. Int J STD AIDS. 1995;6:273-277.
44. Institut National de la Statistique et de la Démographie 1993. Measure DHS- Burkina Faso: DHS, 1993, Final Report. Available: http://www.measuredhs.com/pubs/pdf/FR53/FR53.pdf. Accessed December 10, 2012.
45. Huet C, Ouedraogo A, Konate I, et al. Long term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa. BMC Public Health. 2011;11:700.
46. Nagot N, Ouedraogo A, Weiss HA, et al. Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervicovaginal HIV-1 RNA among women in Burkina Faso. Sex Transm Infect. 2008;84:167-170.
47. UNAIDS. UNAIDS salutes the leadership of Burkina Faso's President. 2012. Available at: http://www.unaids.org/en/resources/presscentre/featurestories/2012/december/20121221burkinapresident/. Accessed December 20, 2012.
48. UNAIDS 2011. World AIDS Day Report. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2011. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/jc2216-worldaidsday-report-2011-en.pdf. Accessed January 5, 2013.
49. Jean K, Gabillard D, Moh R, et al. Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Cote d'Ivoire. J Infect Dis. 2014;209:431-440.
50. Lewden C, Gabillard D, Minga A, et al. CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment inWest Africa. J Acquir Immune Defic Syndr. 2012;59:213-219.
51. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010;15(suppl 1):1-15.
52. Lawn SD, Little F, Bekker LG, et al. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS. 2009;23:335-342.
53. Brinkhof MW, Boulle A, Weigel R, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009;6:e1000066.
54. Mills EJ, Bakanda C, Birungi J, et al. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS. 2011;25:851-855.
55. May M, Boulle A, Phiri S, et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet. 2010;376:449-457.
56. Wandel S, Egger M, Rangsin R, et al. Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex Transm Infect. 2008;84 (suppl 1):i31-i36.
57. McNairy ML, Howard AA, El-Sadr WM. Antiretroviral therapy for prevention of HIV and tuberculosis: a promising intervention but not a panacea. J Acquir Immune Defic Syndr. 2013;63(suppl 2):S200-S207.
58. Low AJ, Konate I, Nagot N, et al. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study. J Acquir Immune Defic Syndr. 2014;65:237-245.
59. Jaquet A, Garanet F, Balestre E, et al. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso. J Int AIDS Soc. 2013;16:18867.
60. Dembele M, Saleri N, Carvalho AC, et al. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int J Tuberc Lung Dis. 2010;14:318-323.
61. Vickerman P, Foss AM, Pickles M, et al. To what extent is the HIV epidemic in southern India driven by commercial sex? A modelling analysis. AIDS. 2010;24:2563-2572.
62. Diabate S, Zannou DM, Geraldo N, et al. Antiretroviral therapy among HIV-1 infected female sex workers in Benin: a comparative study with patients from the general population. World J AIDS. 2011;1:94-99.
63. Meda N, Sangare L, Lankoande S, et al. The HIV epidemic in Burkina Faso: current status and the knowledge level of the population about AIDS, 1994-1995 [in French]. Rev Epidemiol Sante Publique. 1998;46:14-23.
64. Vuylsteke B, Semde G, Sika L, et al. HIV and STI prevalence among female sex workers in Cote d'Ivoire: why targeted prevention programs should be continued and strengthened. PLoS One. 2012;7:e32627.
65. Behanzin L, Diabate S, Minani I, et al. Decline in the prevalence of HIV and sexually transmitted infections among female sex workers in Benin over 15 years of targeted interventions. J Acquir Immune Defic Syndr. 2013;63:126-134.
66. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet. 1994;344:246-248.
67. Eluwa GI, Strathdee SA, Adebajo SB, et al. Sexual risk behaviors and HIV among female sex workers in Nigeria. J Acquir Immune Defic Syndr. 2012;61:507-514.
68. Hallett TB, Gregson S, Mugurungi O, et al. Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics. 2009;1:108-117.
69. Boily MC, Lowndes CM, Vickerman P, et al. Evaluating large-scale HIV prevention interventions: study design for an integrated mathematical modelling approach. Sex Transm Infect. 2007;83:582-589.
70. Halperin DT, Mugurungi O, Hallett TB, et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med. 2011;8:e1000414.
71. Institut National de la Statistique et de la Demographie, ICF International 2010. Burkina Faso DHS 2010-Final Report. Available at: http://www.measuredhs.com/publications/publication-FR256-DHS-Final-Reports.cfm Accessed January 11, 2012.
72. Mtetwa S, Busza J, Chidiya S, et al. "You are wasting our drugs": Health service barriers to HIV treatment for sex workers in Zimbabwe. BMC Public Health. 2013;13:698.
73. Stall R, Duran L, Wisniewski SR, et al. Running in place: implications of HIV incidence estimates among urban men who have sex with men in the United States and other industrialized countries. AIDS Behav. 2009;13:615-629.
74. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Cape Town, South Africa: HSRC Press; 2014.
75. McClelland RS, Graham SM, Richardson BA, et al. Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers. AIDS. 2010;24:891-897.
76. Diabate S, Chamberland A, Zannou DM, et al. Sexual behaviour after antiretroviral therapy initiation in female sex workers and HIVpositive patients from the general population, Cotonou, Benin. AIDS Care. 2013;25:1426-1432.
77. Mawji E, McKinnon L, Wachihi C, et al. Does antiretroviral therapy initiation increase sexual risk taking in Kenyan female sex workers? A retrospective case-control study. BMJ Open. 2012;2:e000565.
78. Kania D, Fao P, Valea D, et al. Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa. J Clin Microbiol. 2010;48:1333-1336.
79. Cianci F, Sweeney S, Konate I, et al. The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso. PLoS One. 2014;9:e100107.